President & CEO

Avidity Biosciences Insider Sold Shares Worth $1,003,058, According to a Recent SEC Filing

Avidity Biosciences to Participate in Upcoming Investor Conference

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026

Global Duchenne Muscular Dystrophy Therapeutics Market to hit $ 6.64 billion by 2033 with Gene Therapy innovations

Senior Director, Regulatory Affairs

Avidity Biosciences, Inc. is dedicated to improving lives through innovative RNA therapeutics. The Senior Director of Regulatory Affairs will lead the global regulatory strategy and oversee regulatory submissions and compliance, working closely with cross-functional teams and regulatory authorities.

Chief Human Resources Officer

Vice President, IP Law

Senior Manager of Regulatory Affairs

Associate Director, CMC Regulatory Affairs

Vice President, Medical Affairs North America

Sign up with Google

Sign in with Google